A novel generation of heparan sulfate mimetics for the treatment of prion diseases
Karim Tarik Adjou(École Nationale Vétérinaire d'Alfort), Corinne Ida Lasmézas(Scripps Research Institute), Dulce Papy-García(Université Paris-Est Créteil), Denis Barritault(Délégation Paris 7), Steve Simoneau(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Dominique Dormont(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Jean‐Philippe Deslys(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Nicole Salès, F. Lamoury(Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Cited by 80
Related Papers
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
|Proceedings of the National Academy of Sciences|2013|864
MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction
|Proceedings of the National Academy of Sciences|2009|299
BSE agent signatures in a goat
|Veterinary Record|2005|244
Heparan Sulfate Is a Cellular Receptor for Purified Infectious Prions
|Journal of Biological Chemistry|2005|175
New Insight into Abnormal Prion Protein Using Monoclonal Antibodies
|Biochemical and Biophysical Research Communications|1999|143